Upcoming Shows & Events

NanoString Breast Cancer Symposium

Clinical relevance of genomic signatures as diagnostic tool for Early Stage Breast Cancer: From innovation to a clinical reality at Hospices Civils de Lyon

SPEAKER: multiple
DATE:

Oct 16, 2018

19.00 to 21.30 CET
LOCATION: Château de Montchat
Salle Eugenie, Place du Château, 69003 LYON

Learn about the experience of Hospices Civils de Lyon with the Prosigna® breast cancer prognostic signature assay that identifies your patients’ 10-year risk of distant recurrence and classifies breast cancer into 1 of the 4 intrinsic subtypes. What is the clinical utility of genomic signatures? For which patients? What consequences for therapeutic decisions? Examples of clinical cases will be presented..

Pr. Gilles Freyer, Professeur de cancérologie, Directeur de l'Institut de Cancérologie des Hospices Civils de Lyon, Service Oncologie Médicale, Hospices Civils de Lyon

Dr. Marion Cortet, Chef de Clinique Assistant des Hôpitaux, Service de Gynécologie-Obstétrique, Hôpital de la Croix Rousse

Dr. Jonathan Lopez, Responsable médical de la Plateforme BIOGENET Sud - Hospices Civils de Lyon

 

REGISTER FOR THIS NANOSTRING EVENT

Area(s) of Interest
Check all that apply

Privacy Policy